Primary Immune Deficiency Treatment Consortium | Primary Immune Deficiency Treatment Consortium

Skip to main content

Search

Join Our Contact Registry

RDCRN Alumni badge

Header Social Media

Main navigation

Our Research
Researchers and Clinicians
Patient and Families
Early Stage Investigators
News and Events
About Us
Podcast
- PIDTC Podcast

A Previously-Funded NIH Rare Diseases Clinical Research Network Consortium

Code

PIDTC

Issue 02 | Spring

Read more about Issue 02 | Spring

A recap of the year’s goals for the 6902 cross-sectional study, and the 6903 and 6904 retrospective studies.

Issue 03 | Summer

Read more about Issue 03 | Summer

Updates from PIDTC Patient Advocacy Groups IDF and SCID Angels, 6901 Prospective SCID, enrollment goals and current accruals, and more.

Pagination

Previous page
Page 3

Subscribe to Primary Immune Deficiency Treatment Consortium

Footer menu

Web Policies
Genetic and Rare Diseases Information Center
Members Login
Contact Us

The Primary Immune Deficiency Treatment Consortium (PIDTC) is a previously funded research group of the Rare Diseases Clinical Research Network (RDCRN), which is funded by the National Institutes of Health (NIH) and led by the National Center for Advancing Translational Sciences (NCATS) through its Division of Rare Diseases Research Innovation (DRDRI). PIDTC received funding under grant number U54AI082973 as a collaboration between NCATS and the National Institute of Allergy and Infectious Diseases (NIAID). This website is hosted by the network’s Data Management and Coordinating Center at Cincinnati Children’s Hospital Medical Center, which is funded by NCATS and the National Institute of Neurological Disorders and Stroke NINDS) under grant number TR002818. The content of this website is solely the responsibility of the PIDTC administrative coordinating center at University of California, San Francisco and does not necessarily represent the official views of the NIH.

social media